+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Veterinary Pharmaceuticals Market by Products (Drugs, Medicinal Feed, Vaccines), Animal Type (Companion Animals, Livestock Animals), Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612994
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Pharmaceuticals Market grew from USD 37.46 billion in 2023 to USD 40.53 billion in 2024. It is expected to continue growing at a CAGR of 8.35%, reaching USD 65.71 billion by 2030.

The veterinary pharmaceuticals market is experiencing dynamic growth driven by evolving disease profiles, rising pet ownership, and the increasing scale of livestock operations. In recent years, industry stakeholders have observed a marked emphasis on innovation and technological advancements, which have driven shifts in treatment methodologies and production techniques. This environment has led to the adoption of robust research and development processes and reinforced the commitment to improving animal health across various segments.

Current market trends demonstrate an emphasis on the integration of scientific research with practical applications in disease management and prevention. Advances in biotechnology, diagnostic tools, and regulatory oversight continue to deepen our understanding of both companion and livestock animal needs. These developments are further fueled by greater consumer awareness of animal welfare and sustainability. As new challenges emerge, the industry is responding with more precise and targeted interventions, positioning veterinary pharmaceuticals at the forefront of an expanded global health initiative for our animal populations.

Transformative Shifts in the Industry Landscape

The industry is undergoing transformative shifts as traditional therapeutic approaches are superseded by innovative treatment modalities and strategic realignments. Over the past few years, there has been a notable transition to personalized veterinary medicine, driven by advanced genomic research and improved diagnostic methods. These changes have altered the conventional paradigms, encouraging the adoption of holistic and technologically driven solutions.

Modernization of manufacturing processes coupled with stringent regulatory frameworks has elevated product quality and safety benchmarks. The competitive landscape has further evolved with strategic mergers, acquisitions, and increased investment in research and development. Enhanced digital platforms and data analytics are now playing pivotal roles in forecasting trends and optimizing supply chain management. The fusion of technology and tradition has sparked new models of care and distribution, ensuring that breakthroughs in innovation benefit a broad range of stakeholders across the industry.

Key Segmentation Insights in the Veterinary Pharmaceuticals Market

In-depth analysis of the market reveals significant insights when examined through multiple segmentation lenses. The product-focused segmentation dissects the market into Drugs, Medicinal Feed, and Vaccines, where drugs are further explored through categories such as Analgesics, Anti-Infectives - which include Antibiotics and Antifungals - Anti-Inflammatories that are split into Non-Steroidal and Steroidal types, as well as Parasiticides categorized into Ectoparasiticides and Endoparasiticides. The medicinal feed segment looks at a variety of formulations from Antibiotic Medicated Feed to Antiparasitic Medicated Feed, Growth Promoters, Nutritional Medicated Feed, and Probiotic & Prebiotic Medicated Feed, while the vaccines are divided between Inactivated and Live formulations.

Further segmentation by animal type distinguishes between Companion Animals and Livestock Animals. Within this, companion segments such as Cats, Dogs, and Horses meet the specialized needs of pet owners, while livestock is classified into Cattle, Poultry, Sheep & Goats, and Swine, each presenting its own unique challenges and opportunities. Additional segmentation using Mode of Administration considers Injectable products - including Intramuscular and Subcutaneous methods - Oral options like Capsules, Liquid Suspensions & Syrups, and Tablets, and Topical applications including Creams, Lotions, and Ointments. The spectrum of Indications covers conditions ranging from Chronic & Acute Pain Management to Infectious Diseases, Immunological Conditions, Metabolic Disorders, Neurological Disorders, Orthopedic Disorders, Parasitic Infections, and Reproductive Health. Lastly, distribution channels such as Online Pharmacies, Retail Pharmacies, and Veterinary Clinics work in tandem with varied End Users encompassing Animal Farms, Pet Owners, and Veterinary Hospitals to create a complex yet robust market framework.

Based on Products, market is studied across Drugs, Medicinal Feed, and Vaccines. The Drugs is further studied across Analgesics, Anti-Infectives, Anti-Inflammatories, and Parasiticides. The Anti-Infectives is further studied across Antibiotics and Antifungals. The Anti-Inflammatories is further studied across Non-Steroidal and Steroidal. The Parasiticides is further studied across Ectoparasiticides and Endoparasiticides. The Medicinal Feed is further studied across Antibiotic Medicated Feed, Antiparasitic Medicated Feed, Growth Promoters, Nutritional Medicated Feed, and Probiotic & Prebiotic Medicated Feed. The Vaccines is further studied across Inactivated Vaccines and Live Vaccines.

Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.

Based on Mode of Administration, market is studied across Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Subcutaneous. The Oral is further studied across Capsules, Liquid Suspension & Syrup, and Tablets. The Topical is further studied across Creams, Lotions, and Ointments.

Based on Indications, market is studied across Chronic & Acute Pain Management, Immunological Conditions, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Orthopedic Disorders, Parasitic Infections, and Reproductive Health.

Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Clinics.

Based on End User, market is studied across Animal Farms, Pet Owners, and Veterinary Hospitals.

Key Regional Insights Across Global Markets

The regional analysis of the veterinary pharmaceuticals market reveals varied trends and opportunities across different parts of the globe. In the Americas, market penetration is largely driven by advanced research facilities, significant investments in product innovations, and a robust regulatory environment, ensuring consistent product quality and safety. Meanwhile, the Europe, Middle East & Africa region stands out due to its distinct regulatory frameworks, a strong focus on companion animal health, and emerging investments aimed at improving livestock operations. This region is emerging as a hub for scientific research and collaborative innovation in veterinary health.

In the Asia-Pacific region, rapid economic growth and urbanization, coupled with an increasing awareness of animal health, are spurring market expansion. The rising middle class is leading to an increase in pet ownership, while intensifying livestock production drives demand for efficient and cost-effective treatments. Each region demonstrates its own strengths and challenges, yet collectively they contribute to the global evolution and diversification of the veterinary pharmaceuticals market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New Jersey, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Veterinary Pharmaceuticals Market

A robust examination of key market players showcases the competitive and innovative spirit that defines the veterinary pharmaceuticals sector. Industry frontrunners such as Aurora Pharmaceutical, Inc. and Biogénesis Bagó S.A. play instrumental roles by consistently introducing breakthrough products that address both routine and specialized animal health challenges. Firms like Biovac Ltd., Boehringer Ingelheim International GmbH, and Ceva Santé Animale are recognized for leveraging advanced technological processes to enhance drug formulations and ensure efficacy.

Equally, companies including Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, and ECO Animal Health Group PLC have expanded their global footprint through strategic partnerships and comprehensive product portfolios. Leading names such as Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., and Intas Pharmaceuticals Ltd. continue to drive market momentum with their research-centric approaches. Moreover, firms like Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, and Phibro Animal Health Corporation ensure diverse representation of niche market segments. The influence of Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc. further underscores the competitive dynamic and strategic depth present in the veterinary pharmaceuticals landscape.

The report delves into recent significant developments in the Veterinary Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Inc., Biogénesis Bagó S.A., Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, ECO Animal Health Group PLC, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc..

Actionable Recommendations for Industry Leaders

To sustain growth and secure a competitive edge, industry leaders must adopt a strategic approach that combines technological innovation with market-specific insights. Emphasizing investment in comprehensive research and development will facilitate the rapid adaptation to emerging pathogens and disease profiles. It is essential for decision-makers to focus on integrating advanced analytics and digital platforms that not only optimize supply chain management but also provide real-time insights into market trends.

Moreover, fostering cross-functional collaborations between research institutions, regulatory agencies, and industry partners can drive faster and more effective product development. Leaders should consider diversifying product portfolios to cater to the nuanced demands of both companion and livestock animal segments, while also tailoring modes of administration to suit diverse market needs. In addition, enhancing customer engagement through educational initiatives and robust post-market surveillance can reinforce trust and ensure sustained market relevance. Strategic expansion into emerging markets, along with localized adaptations, further bolsters opportunities in regions with varying consumer dynamics.

Summarizing the Veterinary Pharmaceuticals Landscape

In summary, the veterinary pharmaceuticals market is at a pivotal juncture, with transformative technological advancements and evolving market dynamics propelling the industry forward. As the landscape becomes increasingly complex, the convergence of innovation, regulatory reforms, and strategic market segmentation is setting the stage for a new era of animal healthcare. Through comprehensive segmentation by product type, animal type, administration mode, and disease indication, stakeholders can gain a deeper understanding of varied consumer needs and operational challenges.

Moreover, the robust regional insights and the strategic initiatives undertaken by top companies underscore the significance of a globally integrated approach. The synthesis of these diverse elements offers a roadmap that not only highlights current achievements but also identifies critical areas for future investment and growth. In this evolving environment, maintaining an agile and forward-looking approach is key to navigating the intricacies of the market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
5.1.1.2. Increase in R&D activities for veterinary healthcare
5.1.2. Restraints
5.1.2.1. Risk of recalls associated with veterinary drugs and vaccines
5.1.3. Opportunities
5.1.3.1. Development of new and advanced veterinary pharmaceuticals
5.1.3.2. Increasing investment by companies for the expansion of veterinary vaccine facilities
5.1.4. Challenges
5.1.4.1. Concerns associated with the adverse effects of veterinary vaccine
5.2. Market Segmentation Analysis
5.2.1. Products: The growing demand for medicinal feed to improve animal health and productivity
5.2.2. Animal Type: Growing need for veterinary pharmaceuticals in livestock animals owing to disease control and productivity enhancement
5.2.3. Mode of Administration: Increasing utilization of capsules for ensuring dosage accuracy
5.2.4. Indications: Emerging focus on the introduction of drugs advancing treatments for metabolic disorders
5.2.5. Distribution Channel: Growing consumer preference for online pharmacies owing to their convenience and wide range of products
5.2.6. End User: Expanding applications of veterinary pharmaceuticals by pet owners
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Veterinary Pharmaceuticals Market, by Products
6.1. Introduction
6.2. Drugs
6.2.1. Analgesics
6.2.2. Anti-Infectives
6.2.2.1. Antibiotics
6.2.2.2. Antifungals
6.2.3. Anti-Inflammatories
6.2.3.1. Non-Steroidal
6.2.3.2. Steroidal
6.2.4. Parasiticides
6.2.4.1. Ectoparasiticides
6.2.4.2. Endoparasiticides
6.3. Medicinal Feed
6.3.1. Antibiotic Medicated Feed
6.3.2. Antiparasitic Medicated Feed
6.3.3. Growth Promoters
6.3.4. Nutritional Medicated Feed
6.3.5. Probiotic & Prebiotic Medicated Feed
6.4. Vaccines
6.4.1. Inactivated Vaccines
6.4.2. Live Vaccines
7. Veterinary Pharmaceuticals Market, by Animal Type
7.1. Introduction
7.2. Companion Animals
7.2.1. Cats
7.2.2. Dogs
7.2.3. Horses
7.3. Livestock Animals
7.3.1. Cattle
7.3.2. Poultry
7.3.3. Sheep & Goats
7.3.4. Swine
8. Veterinary Pharmaceuticals Market, by Mode of Administration
8.1. Introduction
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Subcutaneous
8.3. Oral
8.3.1. Capsules
8.3.2. Liquid Suspension & Syrup
8.3.3. Tablets
8.4. Topical
8.4.1. Creams
8.4.2. Lotions
8.4.3. Ointments
9. Veterinary Pharmaceuticals Market, by Indications
9.1. Introduction
9.2. Chronic & Acute Pain Management
9.3. Immunological Conditions
9.4. Infectious Diseases
9.5. Metabolic Disorders
9.6. Neurological Disorders
9.7. Orthopedic Disorders
9.8. Parasitic Infections
9.9. Reproductive Health
10. Veterinary Pharmaceuticals Market, by Distribution Channel
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies
10.4. Veterinary Clinics
11. Veterinary Pharmaceuticals Market, by End User
11.1. Introduction
11.2. Animal Farms
11.3. Pet Owners
11.4. Veterinary Hospitals
12. Americas Veterinary Pharmaceuticals Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Veterinary Pharmaceuticals Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Veterinary Pharmaceuticals Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Dechra Pharmaceuticals to acquire Invetx to enhance veterinary therapeutics portfolio
15.3.2. TechInvention and Botswana Institute partner to revolutionize veterinary vaccine production
15.3.3. Merck Animal Health introduces innovative RNA-particle Canine Flu vaccine
15.3.4. Huvepharma Expands with EUR 72 million veterinary vaccine plant to boost global supply and innovation
15.3.5. Virbac strengthens position in Japanese market with Sasaeah acquisition
15.3.6. FDA approvals enhance veterinary treatments for heart and respiratory conditions
15.3.7. Impact of EVML on global veterinary medicine accessibility and AMR mitigation
15.3.8. Zendal and CSIC unveil innovative Neoleish vaccine to combat canine leishmaniasis
15.3.9. Merck Animal Health acquires Elanco’s aqua business to strengthen aquaculture presence
15.3.10. Huateng Pharma expands with fluralaner and sarolaner launch, revolutionizing veterinary pharmaceuticals
15.3.11. ENTOD Pharmaceuticals expands into veterinary market with "FUR by ENTOD" division
15.3.12. Indian Immunologicals Ltd (IIL) invests INR 700 crore in Hyderabad vaccine plant to boost livestock disease eradication
15.3.13. Virbac acquires stake in Globion to boost avian vaccine market presence in India
15.3.14. Strategic collaboration between Pirbright Institute and USask's VIDO to boost vaccine innovation and pandemic readiness
15.4. Strategy Analysis & Recommendation
15.4.1. Dechra Pharmaceuticals PLC
15.4.2. Zoetis Inc.
15.4.3. Ceva Santé Animale
15.4.4. Boehringer Ingelheim GmbH
List of Figures
FIGURE 1. VETERINARY PHARMACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY PHARMACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY PHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. VETERINARY PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. VETERINARY PHARMACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIPARASITIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NUTRITIONAL MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PROBIOTIC & PREBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIQUID SUSPENSION & SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CHRONIC & ACUTE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 132. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 133. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 134. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 135. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 136. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 137. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 139. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 140. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 144. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 145. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 150. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 152. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 153. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 160. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 161. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 218. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 220. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 221. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 222. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 223. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 224. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 226. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 227. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 229. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 230. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 231. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 235. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 236. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 237. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 238. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 239. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 240. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 241. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 243. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 244. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 246. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 247. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 248. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 249. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 255. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 256. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 257. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 269. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 270. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 271. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 272. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 273. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 274. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 275. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 276. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 277. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 278. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 280. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 281. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 282. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 283. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 286. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 287. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 288. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 289. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 290. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 291. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 292. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 293. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 294. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 303. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 304. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
TABLE 305. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
TABLE 306. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
TABLE 307. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
TABLE 308. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 309. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 310. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 311. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 312. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 314. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 320. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 321. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANT

Companies Mentioned

  • Aurora Pharmaceutical, Inc.
  • Biogénesis Bagó S.A.
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Phibro Animal Health Corporation
  • Teknofarma S.r.l.
  • Vetoquinol Group
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Virbac S.A.
  • Zendal Group
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 40.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 65.71 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Veterinary Drug Market by Drug Type, Animal Type, Route of Administration - Global Forecast 2025-2030 - Product Image

Veterinary Drug Market by Drug Type, Animal Type, Route of Administration - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (November 4, 2025)

  • Conference
  • 1 Day
  • Global
Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030 - Product Image

Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From

About the Animal Pharmaceuticals Market

The Animal Pharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs and other medical products for animals. These products are used to treat, prevent, and diagnose diseases in animals, as well as to improve their health and well-being. Animal pharmaceuticals are used in a variety of species, including companion animals, livestock, and wildlife. Animal pharmaceuticals are regulated by the Food and Drug Administration (FDA) and the Veterinary Medicine Advisory Committee (VMAC). The FDA is responsible for ensuring the safety and efficacy of animal drugs, while the VMAC provides advice and guidance on the development and approval of animal drugs. Some of the major companies in the Animal Pharmaceuticals market include Zoetis, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, and Boehringer Ingelheim Animal Health. These companies are involved in the development, production, and marketing of animal pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.